PCN21 - Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery

Autor: Vargas-Romero, J.A., Figueroa-Rodriguez, A., Chiu-Ugalde, J., Sánchez-Kobashi, R., Gay-Molina, J.G., López-Alvarenga, J.C.
Zdroj: In Value in Health November 2013 16(7):A686-A686
Databáze: ScienceDirect